May 10, 2018 / 8:12 PM / 6 months ago

BRIEF-Aurinia Reports Qtrly Loss Per Share $0.18

May 10 (Reuters) - Aurinia Pharmaceuticals Inc:

* AURINIA REPORTS FIRST QUARTER FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS

* AURINIA PHARMACEUTICALS INC - AURORA PHASE III TRIAL IN LUPUS NEPHRITIS REMAINS ON TRACK

* AURINIA PHARMACEUTICALS INC - CONTINUE TO BE WELL-CAPITALIZED INTO 2020

* AURINIA PHARMACEUTICALS INC QTRLY LOSS PER SHARE $0.18 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below